AWMSG advice
Rifaximin (Xifaxanta®) is recommended as an option for use within NHS Wales for the treatment of travellers’ diarrhoea that is not associated with any of: fever, bloody diarrhoea, eight or more unformed stools in the previous 24 hours, occult blood or leucocytes in the stool or to shorten the duration of diarrhoea when this is associated with non-invasive strains of E.coli.
